Ledger.Open graph →
SEC Form D · filed March 24, 2021

Monte Rosa Therapeutics, Inc

Offering
$95.0M
Sold
$95.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Ajim P. Tamboli · Boston, MAExecDrew Schiff · Boston, MADirectorJustin Ort · New York, NYDirectorRonald Geraty · Marblehead, MADirectorDrew Schiff · Boston, MADirectorChandra P. Leo · Boston, MADirectorChad Gordon · Cockeysville, MDDirectorKim Blackwell · Boston, MADirectorNicole Quinn · Carlsbad, CADirectorTodd Jackson · Carlsbad, CADirectorChandra P. Leo · Boston, MADirectorLauren Otsuki · Carlsbad, CAExec · DirectorChristine P. Siu · Boston, MADirectorCarol Shen · Carlsbad, CADirectorJordan Albert · Los Angeles, CADirectorAli Behbahani · Boston, MADirectorBradley Bolzon · Boston, MADirectorChristine P. Siu · Boston, MADirectorC/O Aztec Financial Cgr Iv GP S.A.R.L · SENNINGERBERG, LuxembourgExec · DirectorMarkus Warmuth · Boston, MAExec · DirectorAlexander Mayweg · Boston, MADirectorJoshua I. Scheinker · Lutherville, MDDirectorAjim P. Tamboli · Boston, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗